Related Experiment Video
Updated: May 18, 2026
05:45
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Future therapies for Hirschsprung's disease
David J Wilkinson1, David H Edgar, Simon E Kenny
1Department of Paediatric Surgery, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Seminars in Pediatric Surgery
|September 19, 2012
Summary
Current Hirschsprung
Area of Science:
- Developmental biology
- Pediatric surgery
- Gastroenterology
Background:
- Hirschsprung's disease (HSCR) management has limitations, causing long-term issues.
- Advances in understanding enteric nervous system development offer new therapeutic avenues.
- Research is exploring novel treatments for HSCR.
Purpose of the Study:
- To review progress in developing new therapies for HSCR.
- To highlight advancements in understanding HSCR etiology.
- To discuss potential alternative and adjunctive treatments for HSCR.
Main Methods:
- Literature review of recent studies on HSCR.
- Analysis of research on enteric nervous system development.
- Synthesis of information on emerging HSCR therapies.
Main Results:
- Significant progress in understanding HSCR's developmental origins.
- Identification of potential targets for novel therapeutic strategies.
- Exploration of regenerative and genetic approaches for HSCR.
Conclusions:
- New insights into HSCR pathogenesis are paving the way for innovative treatments.
- Future therapies aim to improve outcomes and reduce morbidities in children with HSCR.
- Continued research is crucial for translating developmental biology findings into clinical practice for HSCR.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.